Mechanisms of resistance to immune checkpoint inhibitors and strategies to reverse drug resistance in lung cancer
Abstract. In recent years, the research of immune checkpoint inhibitors has made a great breakthrough in lung cancer treatment. Currently, a variety of immune checkpoint inhibitors have been applied into clinical practice, including antibodies targeting the programmed cell death-1, programmed cell d...
Main Authors: | Fang-Fei Qian, Bao-Hui Han, Pei-Fang Wei |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2020-10-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000001124 |
Similar Items
-
Advance in Drug Resistance Mechanism of Immune Checkpoint Inhibitors
by: ZHANG Lanlan, et al.
Published: (2020-08-01) -
Epigenetic Mechanisms of Resistance to Immune Checkpoint Inhibitors
by: Alexandre Perrier, et al.
Published: (2020-07-01) -
Resistance to immune checkpoint inhibitors in non-small cell lung cancer: biomarkers and therapeutic strategies
by: Robert J. Walsh, et al.
Published: (2020-07-01) -
Mechanisms of Primary and Secondary Resistance to Immune Checkpoint Inhibitors in Cancer
by: Tiffany Seto, et al.
Published: (2019-01-01) -
TGFBR2 mutation predicts resistance to immune checkpoint inhibitors in patients with non-small cell lung cancer
by: Teng Li, et al.
Published: (2021-08-01)